Questionnaire Survey on the Use of Depot Formulation of Leuprorelin Acetate Injection in Patients with Prostate Cancer (QLIPP)

Next Previous
Trial Profile

Questionnaire Survey on the Use of Depot Formulation of Leuprorelin Acetate Injection in Patients with Prostate Cancer (QLIPP)

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Apr 2018

At a glance

  • Drugs Leuprorelin (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms QLIPP

    • Most Recent Events

    • 04 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top